AccessWire: On World Rainforest Day, Jaguar Health Reinforces Commitment to Amazon Rainforest and Sustainable Harvesting Programs for Plant-based Pharmaceuticals

Jaguar Health, Inc.’s (NASDAQ:JAGX) chief of sustainability and ethnobotanist Steven King, Ph.D. was featured on Forest Trends’ Viewpoints, discussing the ancient and powerful medicinal knowledge of Indigenous peoples and local communities in the Amazon Rainforest, the importance of understanding, respecting and conserving this vast body of wisdom along with the rainforests, and the pioneering fair-trade tree-to-bottle development of Mytesi® (crofelemer) – a non-opioid oral plant-based medicine approved by the U.S. Food and Drug Administration for noninfectious diarrhea in adults patients with HIV/AIDS on antiretroviral therapy.